Episode: 41 - Introduction and Evolution of the Antibody Patent Landscape

The Chain: Protein Engineering Podcast

Innehåll tillhandahållet av Cambridge Healthtech Institute. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Cambridge Healthtech Institute eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

1+ y ago 20:30

MP3•Episod hem

After over 25 years as an intellectual property (IP) attorney, Jane Remillard, Nelson Mullins patents and biotechnology IP senior partner, is well-versed in navigating drug development and antibody patent law. In this episode, Remillard speaks with moderator Nimish Gera, Mythic Therapeutics vice president of biologics, about the intersection between science and law, the primary steps recommended to patent a scientific discovery, and how the antibody IP landscape has evolved in recent years. She also talks about the importance of implementing a strategy regarding the number and types of antibody patents filed, her advice to anyone considering a career in IP law, and what to expect from the industry moving forward.

Links from this episode:
Nelson Mullins
Mythic Therapeutics

65 episoder

#Science #Biology #Cambridge Healthtech Institute #Proteins #Protein Engineering #Scientists #RD In #Antibodies #Bispecific Antibodies #Solid Tumors